Cargando…

Coexistent papillary thyroid carcinoma diagnosed in surgically treated patients for primary versus secondary hyperparathyroidism: same incidence, different characteristics

BACKGROUND: The coexistence of hyperparathyroidism and thyroid cancer presents important diagnostic and management challenges. With minimally invasive parathyroid surgery trending, preoperative thyroid imaging becomes more important as concomitant thyroid and parathyroid lesions are reported. The ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Preda, Cristina, Branisteanu, Dumitru, Armasu, Ioana, Danila, Radu, Velicescu, Cristian, Ciobanu, Delia, Covic, Adrian, Grigorovici, Alexandru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636032/
https://www.ncbi.nlm.nih.gov/pubmed/31311533
http://dx.doi.org/10.1186/s12893-019-0556-y
_version_ 1783435991456940032
author Preda, Cristina
Branisteanu, Dumitru
Armasu, Ioana
Danila, Radu
Velicescu, Cristian
Ciobanu, Delia
Covic, Adrian
Grigorovici, Alexandru
author_facet Preda, Cristina
Branisteanu, Dumitru
Armasu, Ioana
Danila, Radu
Velicescu, Cristian
Ciobanu, Delia
Covic, Adrian
Grigorovici, Alexandru
author_sort Preda, Cristina
collection PubMed
description BACKGROUND: The coexistence of hyperparathyroidism and thyroid cancer presents important diagnostic and management challenges. With minimally invasive parathyroid surgery trending, preoperative thyroid imaging becomes more important as concomitant thyroid and parathyroid lesions are reported. The aim of the study was to evaluate the rate of thyroid cancer in patients operated for either primary (PHPT) or secondary hyperparathyroidism (SHPT). METHODS: Our retrospective study included PHPT and SHPT patients submitted to parathyroidectomy and, when indicated, concomitant thyroid surgery between 2010 and 2017. RESULTS: Parathyroidectomy was performed in 217 patients: 140 (64.5%) for PHPT and 77 (35.5%) for SHPT. Concomitant thyroid surgery was performed in 75 patients with PHPT (53.6%), and 19 papillary thyroid carcinomas (PTC) were found, accounting for 13.6% from all cases with PHPT and 25.3% from PHPT cases with concomitant thyroid surgery. Thirty-one of operated SHPT patients (40.3%) also underwent thyroid surgery and 9 PTC cases were diagnosed (11.7% of all SHPT patients and 29% of patients with concomitant thyroid surgery). We found differences between PHPT and SHPT patients (p < 0.001) with respect to age (54.6 ± 13y versus 48.8 ± 12y), female-to-male ratio (8:1 versus ~ 1:1), surgical technique (single gland parathyroidectomy in 82.8% PHPT cases; versus subtotal parathyroidectomy in 85.7% SHPT cases) and presurgical PTH (357.51 ± 38.11 pg/ml versus 1020 ± 161.38 pg/ml). Morphopathological particularities, TNM classification and multifocality incidence of PTC were similar in the two groups. All PTC from patients with SHPT were thyroid microcarcinomas (TMC, i.e. tumors with a diameter smaller than 1 cm), whereas seven out of the 19 cases with PTC and PHPT were larger than 1 cm. CONCLUSIONS: PTC was frequently and similarly associated with both PHPT and SHPT irrespective of presurgical PTH levels. Thyroid tumors above 1 cm were found only in patients with PHPT. Investigators should focus also on associated thyroid nodular pathology in patients with PHPT.
format Online
Article
Text
id pubmed-6636032
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-66360322019-07-25 Coexistent papillary thyroid carcinoma diagnosed in surgically treated patients for primary versus secondary hyperparathyroidism: same incidence, different characteristics Preda, Cristina Branisteanu, Dumitru Armasu, Ioana Danila, Radu Velicescu, Cristian Ciobanu, Delia Covic, Adrian Grigorovici, Alexandru BMC Surg Research Article BACKGROUND: The coexistence of hyperparathyroidism and thyroid cancer presents important diagnostic and management challenges. With minimally invasive parathyroid surgery trending, preoperative thyroid imaging becomes more important as concomitant thyroid and parathyroid lesions are reported. The aim of the study was to evaluate the rate of thyroid cancer in patients operated for either primary (PHPT) or secondary hyperparathyroidism (SHPT). METHODS: Our retrospective study included PHPT and SHPT patients submitted to parathyroidectomy and, when indicated, concomitant thyroid surgery between 2010 and 2017. RESULTS: Parathyroidectomy was performed in 217 patients: 140 (64.5%) for PHPT and 77 (35.5%) for SHPT. Concomitant thyroid surgery was performed in 75 patients with PHPT (53.6%), and 19 papillary thyroid carcinomas (PTC) were found, accounting for 13.6% from all cases with PHPT and 25.3% from PHPT cases with concomitant thyroid surgery. Thirty-one of operated SHPT patients (40.3%) also underwent thyroid surgery and 9 PTC cases were diagnosed (11.7% of all SHPT patients and 29% of patients with concomitant thyroid surgery). We found differences between PHPT and SHPT patients (p < 0.001) with respect to age (54.6 ± 13y versus 48.8 ± 12y), female-to-male ratio (8:1 versus ~ 1:1), surgical technique (single gland parathyroidectomy in 82.8% PHPT cases; versus subtotal parathyroidectomy in 85.7% SHPT cases) and presurgical PTH (357.51 ± 38.11 pg/ml versus 1020 ± 161.38 pg/ml). Morphopathological particularities, TNM classification and multifocality incidence of PTC were similar in the two groups. All PTC from patients with SHPT were thyroid microcarcinomas (TMC, i.e. tumors with a diameter smaller than 1 cm), whereas seven out of the 19 cases with PTC and PHPT were larger than 1 cm. CONCLUSIONS: PTC was frequently and similarly associated with both PHPT and SHPT irrespective of presurgical PTH levels. Thyroid tumors above 1 cm were found only in patients with PHPT. Investigators should focus also on associated thyroid nodular pathology in patients with PHPT. BioMed Central 2019-07-16 /pmc/articles/PMC6636032/ /pubmed/31311533 http://dx.doi.org/10.1186/s12893-019-0556-y Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Preda, Cristina
Branisteanu, Dumitru
Armasu, Ioana
Danila, Radu
Velicescu, Cristian
Ciobanu, Delia
Covic, Adrian
Grigorovici, Alexandru
Coexistent papillary thyroid carcinoma diagnosed in surgically treated patients for primary versus secondary hyperparathyroidism: same incidence, different characteristics
title Coexistent papillary thyroid carcinoma diagnosed in surgically treated patients for primary versus secondary hyperparathyroidism: same incidence, different characteristics
title_full Coexistent papillary thyroid carcinoma diagnosed in surgically treated patients for primary versus secondary hyperparathyroidism: same incidence, different characteristics
title_fullStr Coexistent papillary thyroid carcinoma diagnosed in surgically treated patients for primary versus secondary hyperparathyroidism: same incidence, different characteristics
title_full_unstemmed Coexistent papillary thyroid carcinoma diagnosed in surgically treated patients for primary versus secondary hyperparathyroidism: same incidence, different characteristics
title_short Coexistent papillary thyroid carcinoma diagnosed in surgically treated patients for primary versus secondary hyperparathyroidism: same incidence, different characteristics
title_sort coexistent papillary thyroid carcinoma diagnosed in surgically treated patients for primary versus secondary hyperparathyroidism: same incidence, different characteristics
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636032/
https://www.ncbi.nlm.nih.gov/pubmed/31311533
http://dx.doi.org/10.1186/s12893-019-0556-y
work_keys_str_mv AT predacristina coexistentpapillarythyroidcarcinomadiagnosedinsurgicallytreatedpatientsforprimaryversussecondaryhyperparathyroidismsameincidencedifferentcharacteristics
AT branisteanudumitru coexistentpapillarythyroidcarcinomadiagnosedinsurgicallytreatedpatientsforprimaryversussecondaryhyperparathyroidismsameincidencedifferentcharacteristics
AT armasuioana coexistentpapillarythyroidcarcinomadiagnosedinsurgicallytreatedpatientsforprimaryversussecondaryhyperparathyroidismsameincidencedifferentcharacteristics
AT danilaradu coexistentpapillarythyroidcarcinomadiagnosedinsurgicallytreatedpatientsforprimaryversussecondaryhyperparathyroidismsameincidencedifferentcharacteristics
AT velicescucristian coexistentpapillarythyroidcarcinomadiagnosedinsurgicallytreatedpatientsforprimaryversussecondaryhyperparathyroidismsameincidencedifferentcharacteristics
AT ciobanudelia coexistentpapillarythyroidcarcinomadiagnosedinsurgicallytreatedpatientsforprimaryversussecondaryhyperparathyroidismsameincidencedifferentcharacteristics
AT covicadrian coexistentpapillarythyroidcarcinomadiagnosedinsurgicallytreatedpatientsforprimaryversussecondaryhyperparathyroidismsameincidencedifferentcharacteristics
AT grigorovicialexandru coexistentpapillarythyroidcarcinomadiagnosedinsurgicallytreatedpatientsforprimaryversussecondaryhyperparathyroidismsameincidencedifferentcharacteristics